Table 4.
Univariate Preprocedure Predictors of Symptom Improvement With Valvuloplasty
| Predictor | OR (95% CI) | AUC | Optimal Cut Point | P Value |
|---|---|---|---|---|
| Demographics | ||||
| Age | 0.97 (0.93–1.01) | 0.593 | 50 | 0.07 |
| BMI | 0.91 (0.84–0.99) | 0.638 | 32.1 | 0.02 |
| AF | 0.33 (0.12–0.96) | 0.590 | ··· | 0.04 |
| Echocardiography | ||||
| MG | 1.18 (1.02–1.36) | 0.641 | 10 | 0.01 |
| Low gradient <10 mm Hg | 0.33 (0.13–0.85) | 0.630 | ··· | 0.02 |
| MVA | 0.32 (0.04–2.57) | 0.564 | ··· | 0.3 |
| SVI | 0.99 (0.95–1.04) | 0.521 | ··· | 0.7 |
| LA volume index, mL/m2 | 1.02 (0.99–1.05) | 0.576 | ··· | 0.2 |
| RV systolic pressure | 0.99 (0.98–1.02) | 0.495 | ··· | 0.9 |
| LV mass index | 0.99 (0.97–1.01) | 0.525 | ··· | 0.4 |
| EF | 1.01 (0.94–1.08) | 0.493 | ··· | 0.8 |
| Catheterization | ||||
| Ees | 0.83 (0.63–1.10) | 0.589 | ··· | 0.2 |
| Ea | 0.72 (0.27–1.92) | 0.551 | ··· | 0.5 |
| Ea/Ees | 1.27 (0.11–14.12) | 0.569 | ··· | 0.9 |
| Stiffness constant β | 0.40 (0.16–0.97) | 0.735 | 6 | 0.02 |
| MVA | 1.45 (0.48–4.41) | 0.545 | ··· | 0.5 |
| MG | 1.13 (0.99–1.28) | 0.610 | 9 | 0.05 |
| LA pressure | 0.97 (0.90–1.04) | 0.572 | ··· | 0.3 |
| LV end‐diastolic pressure | 0.84 (0.75–0.93) | 0.735 | 15 | 0.0005 |
AF indicates atrial fibrillation; AUC, area under the curve; BMI, body mass index; Ea, effective arterial elastance; Ea/Ees, effective arterial elastance/end‐systolic elastance ventricular vascular coupling; Ees, end‐systolic elastance; EF, ejection fraction; LA, left atrial; LV, left ventricular; MG, mean gradient; MVA, mitral valve area; OR, odds ratio; RV, right ventricular; SVI, stroke volume index.